What is the recommended dose and duration of corticosteroids (steroids) for treating severe vestibular vertigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steroid Dosing for Severe Vestibular Vertigo

For severe vestibular vertigo, intratympanic dexamethasone (4-24 mg/mL) or methylprednisolone (30-62.5 mg/mL) should be administered at a volume of 0.4-0.8 mL into the middle ear space, with 3-4 sessions every 3-7 days depending on clinical response. 1

Diagnosis and Treatment Algorithm

Step 1: Determine Specific Vestibular Diagnosis

  • Distinguish between different causes of vertigo:
    • Ménière's disease: Episodic vertigo with fluctuating hearing loss, tinnitus, aural fullness
    • Vestibular neuritis: Acute prolonged vertigo without hearing loss
    • BPPV: Brief positional vertigo lasting seconds to minutes
    • Labyrinthitis: Sudden severe vertigo with hearing loss

Step 2: Steroid Treatment Protocol Based on Diagnosis

For Ménière's Disease:

  • Intratympanic (IT) steroid therapy:

    • Dexamethasone: 4-24 mg/mL (stock or compounded)
    • Methylprednisolone: 30-62.5 mg/mL (stock or compounded)
    • Volume: 0.4-0.8 mL injected into middle ear space
    • Frequency: 3-4 sessions every 3-7 days 1
  • Oral steroid alternative:

    • Prednisone: 0.35 mg/kg daily for up to 18 weeks 2
    • This regimen has shown to reduce frequency and duration of vertigo episodes by 50% and 30% respectively

For Vestibular Neuritis:

  • Methylprednisolone: Initial high dose (32 mg/day) with tapering over 3-4 weeks 3, 4
  • Corticosteroid therapy enhances earlier resolution of symptoms compared to vestibular exercises alone

Efficacy and Evidence Considerations

  • IT steroid therapy shows 31-90% complete vertigo control in Ménière's disease 1
  • IT steroids have lower risk of hearing loss (0-8%) compared to gentamicin therapy (12.5-15.4%) 1
  • Oral prednisone helps control refractory vertigo in Ménière's disease with minimal side effects 2
  • Methylprednisolone is significantly more effective than placebo in reducing vertiginous symptoms in acute vestibular vertigo 3

Important Caveats and Precautions

  • Vestibular suppressant medications (antihistamines, benzodiazepines) should not be used as primary treatment for vertigo but may be appropriate for short-term management of severe vegetative symptoms (nausea, vomiting) 1
  • These medications can interfere with central compensation in peripheral vestibular conditions
  • Steroid therapy is most effective when initiated early (ideally within first 14 days of symptom onset) 1
  • Reassess patients within 1 month after initial treatment to confirm symptom resolution 1
  • For patients with BPPV, repositioning maneuvers are preferred over medication therapy 1

Treatment Duration Considerations

  • For acute vestibular vertigo: Short course of high-dose steroids with taper over 3-4 weeks
  • For Ménière's disease: IT injections typically require 3-4 sessions
  • For refractory cases: Extended oral prednisone therapy may be considered (up to 18 weeks) 2

The evidence suggests that early intervention with appropriate steroid therapy significantly improves outcomes in severe vestibular vertigo, with the specific regimen depending on the underlying diagnosis.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral administration of prednisone to control refractory vertigo in Ménière's disease: a pilot study.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2005

Research

The beneficial effect of methylprednisolone in acute vestibular vertigo.

Archives of otolaryngology--head & neck surgery, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.